13F Filings History of OLD REPUBLIC INTERNATIONAL CORP

Latest 13F report
Q4 2025 - 09 Feb 2026
Value $
$2,475,563,000
Signature - Title
Phillip Schutt - Sr. Vice President - Investments
Location
Chicago, IL
Summary
This page shows a list of all the recent 13F filings made by OLD REPUBLIC INTERNATIONAL CORP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. OLD REPUBLIC INTERNATIONAL CORP reported 54 stock holdings with total value $2,475,563,000 as of Q4 2025. Top holdings included XOM, QCOM, MRK, CVX, and KO.

Notify me when OLD REPUBLIC INTERNATIONAL CORP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 54 $2,475,563,000 +$67,553,762 -$320,091,186 -$252,537,424 XOM, QCOM, MRK, CVX, KO 13F-HR 09 Feb 2026, 08:53
Q3 2025 56 $2,696,833,000 +$49,697,070 -$15,170,000 +$34,527,070 CMI, CAT, CSCO, XOM, ETN 13F-HR 27 Oct 2025, 09:31
Q2 2025 55 $2,550,578,000 +$24,258,765 -$44,271,000 -$20,012,235 CSCO, PG, XOM, ETN, TXN 13F-HR 09 Jul 2025, 13:55
Q1 2025 57 $2,574,394,000 +$43,750,243 -$61,760,512 -$18,010,269 PG, XOM, CVX, KO, CSCO 13F-HR 29 Apr 2025, 17:08
Q4 2024 55 $2,538,551,000 +$22,464,000 -$28,862,249 -$6,398,249 PG, XOM, CMI, ETN, CSCO 13F-HR 04 Feb 2025, 10:37
Q3 2024 54 $2,666,389,000 $0 $0 $0 PG, XOM, QCOM, KO, TXN 13F-HR 25 Oct 2024, 16:40
Q2 2024 54 $2,455,591,000 $0 -$1,558,824 -$1,558,824 QCOM, PG, XOM, CVX, MRK 13F-HR 29 Jul 2024, 10:44
Q1 2024 54 $2,542,622,000 $0 -$322,247,588 -$322,247,588 XOM, PG, MRK, CVX, QCOM 13F-HR 29 Apr 2024, 08:21
Q4 2023 58 $2,653,850,000 +$44,041,176 -$196,164,006 -$152,122,830 QCOM, HUBB, CAT, PG, XOM 13F-HR 06 Feb 2024, 18:16
Q3 2023 59 $2,678,655,000 +$31,845,933 -$306,727,029 -$274,881,096 XOM, CVX, CAT, HUBB, PG 13F-HR 06 Nov 2023, 09:33
Q2 2023 61 $3,047,930,000 $0 -$72,234,876 -$72,234,876 HUBB, MRK, CAT, XOM, CVX 13F-HR 04 Aug 2023, 09:17
Q1 2023 61 $3,126,667,000 +$13,495,961 -$97,521,970 -$84,026,009 XOM, CVX, MRK, QCOM, CAT 13F-HR 18 May 2023, 13:46
Q4 2022 62 $3,187,670,000 +$20,933,000 -$260,366,318 -$239,433,318 CVX, NUE, XOM, MRK, CAT 13F-HR 21 Feb 2023, 17:18
Q3 2022 63 $3,011,639,000 $0 -$905,064,355 -$905,064,355 XOM, CAT, VZ, PFE, CVX 13F-HR 17 Nov 2022, 18:36
Q2 2022 79 $4,145,059,000 +$33,348,000 -$522,904,289 -$489,556,289 XOM, KO, VZ, CVX, CAT 13F-HR 12 Aug 2022, 16:19
Q1 2022 87 $4,929,317,000 +$17,880,000 -$547,513,397 -$529,633,397 CAT, XOM, CVX, KO, VZ 13F-HR 13 May 2022, 14:09
Q4 2021 92 $5,262,361,000 +$40,723,199 -$13,166,227 +$27,556,972 QCOM, CAT, PG, VZ, PFE 13F-HR 17 Feb 2022, 15:43
Q3 2021 92 $4,789,302,000 +$127,215,626 -$309,873,166 -$182,657,540 VZ, CAT, PG, KO, XOM 13F-HR 04 Nov 2021, 10:17
Q2 2021 92 $5,164,679,000 +$809,042,996 $0 +$809,042,996 CAT, VZ, XOM, CVX, KO 13F-HR 29 Jul 2021, 13:50
Q1 2021 85 $4,235,102,000 +$38,157,517 -$194,683,930 -$156,526,413 CAT, VZ, XOM, CVX, T 13F-HR 17 May 2021, 13:00
Q4 2020 86 $4,022,229,000 $0 $0 $0 VZ, CAT, KO, QCOM, PG 13F-HR 03 Mar 2021, 09:41
Q3 2020 86 $3,654,154,000 +$49,135,000 -$6,545,947 +$42,589,053 VZ, PG, T, KO, CAT 13F-HR 04 Nov 2020, 12:14
Q2 2020 83 $3,532,682,000 $0 -$7,457,000 -$7,457,000 VZ, T, CVX, XOM, PG Restatement 04 Nov 2020, 11:29
Q1 2020 84 $3,188,550,000 +$244,298,709 -$114,934,110 +$129,364,599 VZ, T, KO, PG, XOM 13F-HR 06 May 2020, 17:34
Q4 2019 83 $3,998,229,000 +$385,823,864 -$258,335,259 +$127,488,605 T, VZ, XOM, CVX, KO 13F-HR 29 Jan 2020, 11:13
Q3 2019 86 $3,738,874,000 +$101,868,198 -$307,719,479 -$205,851,281 T, VZ, KO, CVX, PG 13F-HR 31 Oct 2019, 13:32
Q2 2019 87 $3,863,926,000 +$140,391,097 -$36,555,393 +$103,835,704 VZ, T, CVX, KO, XOM 13F-HR 13 Aug 2019, 09:53
Q1 2019 88 $3,712,435,000 +$219,917,445 -$224,487,589 -$4,570,144 VZ, T, CVX, XOM, KO 13F-HR 26 Apr 2019, 11:30
Q4 2018 93 $3,353,633,000 +$318,398,724 -$120,003,000 +$198,395,724 VZ, T, CVX, XOM, KO 13F-HR 28 Jan 2019, 19:05
Q3 2018 93 $3,444,382,000 +$78,968,533 -$16,055,659 +$62,912,874 VZ, T, CVX, XOM, BP 13F-HR 31 Oct 2018, 11:00
Q2 2018 89 $3,242,708,000 +$294,782,922 -$227,675,889 +$67,107,033 VZ, T, CVX, XOM, RDSB 13F-HR 03 Aug 2018, 11:32
Q1 2018 84 $3,122,053,000 +$104,312,417 $0 +$104,312,417 T, VZ, CVX, RDSB, BP Restatement 18 May 2018, 12:52
Q4 2017 82 $3,148,515,000 +$450,185,576 -$459,399,970 -$9,214,394 T, VZ, CVX, RDSB, BP 13F-HR 20 Feb 2018, 10:19
Q3 2017 92 $3,023,918,000 +$108,211,303 -$266,673,834 -$158,462,531 T, VZ, CVX, RDSB, DWDP 13F-HR 01 Nov 2017, 09:53
Q2 2017 94 $3,067,071,000 +$164,618,753 $0 +$164,618,753 T, VZ, CVX, CAT, PM 13F-HR 02 Aug 2017, 15:36
Q1 2017 92 $2,901,660,000 +$98,230,872 -$39,634,000 +$58,596,872 T, VZ, CVX, CAT, IBM 13F-HR 22 May 2017, 09:08
Q4 2016 88 $2,786,976,000 +$37,908,136 -$24,283,000 +$13,625,136 T, VZ, CVX, CAT, IBM 13F-HR 31 Jan 2017, 10:22
Q3 2016 90 $1,654,013,000 $0 $0 $0 T, CVX, VZ, BP, IBM 13F-HR 17 Nov 2016, 10:04
Q2 2016 87 $2,237,969,000 +$126,229,558 -$26,268,983 +$99,960,575 T, VZ, CVX, GSK, RDSB 13F-HR 02 Aug 2016, 16:39
Q1 2016 83 $2,027,521,000 +$253,211,025 -$235,724,442 +$17,486,583 T, VZ, GSK, CVX, MCY 13F-HR 25 May 2016, 11:11
Q4 2015 89 $1,865,447,000 +$74,241,850 -$109,911,309 -$35,669,459 T, VZ, GSK, CVX, GE 13F-HR 25 Feb 2016, 18:45
Q3 2015 88 $1,159,964,000 +$220,587,937 -$79,839,000 +$140,748,937 T, VZ, GSK, GE, PG 13F-HR 04 Nov 2015, 12:53
Q2 2015 86 $1,744,624,000 +$27,641,149 -$28,530,598 -$889,449 T, VZ, BP, CVX, COP 13F-HR 05 Aug 2015, 17:27
Q1 2015 84 $1,792,615,000 +$86,420,984 -$33,317,772 +$53,103,212 T, VZ, CVX, BP, GSK 13F-HR 18 Jun 2015, 10:39
Q4 2014 87 $1,749,439,000 +$495,321,449 -$53,848,304 +$441,473,145 T, VZ, CVX, COP, BP 13F-HR 27 Feb 2015, 16:52
Q3 2014 86 $1,232,238,000 +$125,692,109 -$32,170,105 +$93,522,004 T, MCD, VZ, MCY, INTC 13F-HR 07 Nov 2014, 08:28
Q2 2014 87 $1,149,442,000 +$265,145,247 -$95,814,739 +$169,330,508 T, VZ, COP, CVX, INTC 13F-HR 06 Aug 2014, 15:26
Q1 2014 91 $940,105,000 +$349,312,056 -$185,330,000 +$163,982,056 T, VZ, MO, KMB, COP 13F-HR 06 May 2014, 15:52
Q4 2013 64 $763,425,000 $0 $0 $0 VRSK, VZ, T, LMT, RTN Restatement 14 Feb 2014, 18:49